Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

Bicalutamide improves hair density in women safely.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Birth control pills are effective for treating women with too much male hormone.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.